| Revenue growth | Q2 +19.9%, H1 +18.4% YoY |
|---|---|
| Margins | Gross margin 53.9% vs 57.7%; operating EBITDA margin 6.7% vs 6.4% |
| Demand visibility | Festive demand shifted to Q3; H1 plus Q3 seen as true view |
Growth
H1 FY27 revenue INR 8,569.0 mn, +18.4% YoY. Q2 operating EBITDA INR 305.0 mn, +25.8%, 6.7% margin.
Outlook
FY27 capex INR 1,000-1,200 mn, about 80% for retail; first jumbo store in Bengaluru targeted Q2 FY28. No explicit growth guidance.
Risks
Elevated Polyol/TDI input costs, West Asia logistics disruption, festive demand shifted into Q3, INR 64.3 mn deferred tax charge.
Investor Presentation filed with NSE, NSE: WAKEFIT. Summary written with AI assistance from the document.
Wakefit Innovations Ltd: key numbers
- Share price
- ₹134.92
- Market cap
- ₹4,475 Cr
- Revenue (annual)
- ₹1,489 Cr
- Net profit (annual)
- ₹189.2 Cr
- P/E (TTM)
- 23.2×Sector 36.2×
- Promoter holding
- 37.07%+0.19% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wakefit Innovations Ltd
All →Wakefit Innovations Earnings Call Transcript: Key Takeaways
Wakefit reported record Q2 revenue but faced margin pressure from volatile raw material costs and leadership transitions in key segments.
Wakefit Innovations Results Update
Wakefit Innovations reported record Q2 FY27 revenue of INR 4,519.9 mn, up 19.9% YoY, in an unaudited press release. Profit after tax excluding deferred tax rose 39.9%.
Wakefit Innovations Q2 FY27 Results: Net Profit ₹15.9 Cr, Down 0.6% YoY
Wakefit Innovations Ltd reported revenue from operations of ₹452 Cr (+19.9% YoY) and net profit of ₹15.9 Cr (-0.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹15.9 Cr · -0.6% YoY
Wakefit Innovations Board Meeting Date
Wakefit Innovations will hold a board meeting on 12 November 2026 to consider September quarter results. Trading window closes from 1 October to 14 November 2026.
Wakefit Innovations Other Announcement
Wakefit Innovations Ltd has submitted the quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended September 30, 2026.
Wakefit Innovations Employee Stock Options
Wakefit Innovations Limited has granted 2,25,442 employee stock options under its ESOP-2019 plan. These options are exercisable into equity shares at a price of Rs. 1 each.